Oncol Rep. 2022 Dec;48(6):212. doi: 10.3892/or.2022.8427. Epub 2022 Oct 20.
PMID:36263622
Identification of Niche-Specific Gene Signatures between Malignant Tumor Microenvironments by Integrating Single Cell and Spatial Transcriptomics Data.
Saqib J, Park B, Jin Y, Seo J, Mo J, Kim J.
Genes (Basel). 2023 Oct 31;14(11):2033. doi: 10.3390/genes14112033.
PMID:38002976
Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Uterine epithelioid smooth muscle tumor of uncertain malignant potential.
Gomez NF, Zhao J, Smith B.
Int J Gynecol Cancer. 2023 Aug 7;33(8):1324-1325. doi: 10.1136/ijgc-2022-004117.
PMID:37268311
High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies.
Kim Y, Kim D, Sung WJ, Hong J.
Front Immunol. 2022 Feb 15;13:837004. doi: 10.3389/fimmu.2022.837004. eCollection 2022.
PMID:35242139
Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.